Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 246

1.

[Arthritis psoriatica].

de Rie MA, van Kuijk AW, Goedkoop AY, Tak PP.

Ned Tijdschr Geneeskd. 2007 Aug 4;151(31):1716-22. Review. Dutch.

PMID:
17784693
[PubMed - indexed for MEDLINE]
2.

Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology.

Mease P.

Curr Rheumatol Rep. 2006 Oct;8(5):348-54. Review.

PMID:
16973108
[PubMed - indexed for MEDLINE]
3.

Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.

Taylor SL, Petrie M, O'Rourke KS, Feldman SR.

J Dermatolog Treat. 2009;20(6):350-3. doi: 10.3109/09546630902817887.

PMID:
19878036
[PubMed - indexed for MEDLINE]
4.

Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis.

Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M; Italian Society for Rheumatology.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):70-8.

PMID:
16539822
[PubMed - indexed for MEDLINE]
5.

Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.

Pomerantz RG, Mody E, Husni ME, Qureshi AA.

J Drugs Dermatol. 2009 Apr;8(4):406-12.

PMID:
19363860
[PubMed - indexed for MEDLINE]
6.

Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.

Victor FC, Gottlieb AB, Menter A.

Clin Dermatol. 2003 Sep-Oct;21(5):392-7. Review.

PMID:
14678719
[PubMed - indexed for MEDLINE]
7.

Psoriatic arthritis: pharmacotherapy update.

Mease PJ.

Curr Rheumatol Rep. 2010 Aug;12(4):272-80. doi: 10.1007/s11926-010-0108-z. Review.

PMID:
20490726
[PubMed - indexed for MEDLINE]
8.

Recent advances in the management of psoriatic arthritis.

Mease PJ.

Curr Opin Rheumatol. 2004 Jul;16(4):366-70. Review.

PMID:
15201598
[PubMed - indexed for MEDLINE]
9.

[Psoriatic arthritis: what the dermatologist needs to know, Part 2].

López-Ferrer A, Torrente-Segarra V, Puig L.

Actas Dermosifiliogr. 2010 Nov;101(9):742-8. Review. Spanish.

PMID:
21034704
[PubMed - indexed for MEDLINE]
10.

Resistant cases of psoriatic arthritis: how to manage them.

Atzeni F, Sarzi-Puttini P, Vena GA.

J Rheumatol Suppl. 2009 Aug;83:73-5. doi: 10.3899/jrheum.090232.

PMID:
19661549
[PubMed - indexed for MEDLINE]
11.

Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.

Gladman DD.

Drugs. 2005;65(9):1223-38. Review.

PMID:
15916449
[PubMed - indexed for MEDLINE]
12.

Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.

Coates LC, Helliwell PS.

Rheumatology (Oxford). 2010 Sep;49(9):1793-4; author reply 1794. doi: 10.1093/rheumatology/keq138. Epub 2010 May 10. No abstract available.

PMID:
20457729
[PubMed - indexed for MEDLINE]
Free Article
13.

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update.

Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B; Club Rhumatismes et Inflammation (CRI/SFR).

Joint Bone Spine. 2007 Dec;74(6):638-46. Epub 2007 Nov 8.

PMID:
18065252
[PubMed - indexed for MEDLINE]
14.

Psoriatic arthritis: a dermatologist's perspective.

Snyder RA.

Am J Clin Dermatol. 2010;11 Suppl 1:19-22. doi: 10.2165/1153416-S0-000000000-00000. Review.

PMID:
20586501
[PubMed - indexed for MEDLINE]
15.

Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis.

Myers W, Opeola M, Gottlieb AB.

Curr Rheumatol Rep. 2004 Aug;6(4):306-13. Review.

PMID:
15251083
[PubMed - indexed for MEDLINE]
16.

Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices.

Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, Stevens SR.

J Dermatolog Treat. 2006;17(5):279-87.

PMID:
17092858
[PubMed - indexed for MEDLINE]
17.

Psoriatic arthritis: update on pathophysiology, assessment and management.

Mease PJ.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i77-84. doi: 10.1136/ard.2010.140582. Review.

PMID:
21339225
[PubMed - indexed for MEDLINE]
18.

Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Kane D, FitzGerald O.

Curr Rheumatol Rep. 2004 Aug;6(4):292-8. Review.

PMID:
15251081
[PubMed - indexed for MEDLINE]
19.

UK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register.

Kay LJ, Griffiths ID; BSR Biologics Register Management committee.

Rheumatology (Oxford). 2006 Nov;45(11):1376-9. Epub 2006 Oct 10.

PMID:
17040892
[PubMed - indexed for MEDLINE]
Free Article
20.

New biologics for psoriasis and psoriatic arthritis.

Rozenblit M, Lebwohl M.

Dermatol Ther. 2009 Jan-Feb;22(1):56-60. doi: 10.1111/j.1529-8019.2008.01216.x. Review.

PMID:
19222517
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk